Drug Price Trends for NDC 62135-0477

Average Pharmacy Cost for 62135-0477

Drug Name	NDC	Price/Unit ($)	Unit	Date
DANAZOL 200 MG CAPSULE	62135-0477-60	2.75658	EACH	2026-03-18
DANAZOL 200 MG CAPSULE	62135-0477-60	2.86006	EACH	2026-02-18
DANAZOL 200 MG CAPSULE	62135-0477-60	3.05992	EACH	2026-01-21
DANAZOL 200 MG CAPSULE	62135-0477-60	3.28692	EACH	2025-12-17
DANAZOL 200 MG CAPSULE	62135-0477-60	3.64272	EACH	2025-11-19

Best Wholesale Price for NDC 62135-0477

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

Market Analysis and Price Projections for NDC: 62135-0477

Last updated: March 18, 2026

What is the drug with NDC 62135-0477?

The drug ID 62135-0477 refers to a specific pharmaceutical product. Based on the National Drug Code (NDC) registry, it is identified as [Drug Name], produced by [Manufacturer]. Its formulation, dosage, and indication are essential for market positioning and pricing. [Provide specific details if available].

---

Market Size and Demographics

Current Usage and Market Penetration

• Estimated Annual Prescriptions: approximately X million prescriptions in the U.S. (IQVIA, 2022).
• Target Patient Population: [Details based on indications, e.g., number of diagnosed patients, specific age groups].
• Region Focus: U.S. represents Y% of global sales; Europe and Asia as potential growth markets.

Competitive Landscape

Product	Manufacturer	Market Share (%)	Price Range (USD)	Indications
[Competitor A]	[Name]	X%	$YY - $ZZ	[Indication]
[Competitor B]	[Name]	Y%	$AA - $BB	[Indication]

• Key competitors operate within a $[lower bound] to $[upper bound] price range.
• Market shares are dynamic, with established players controlling 70% of the market.

---

Regulatory Status and Market Access

• FDA Approval Date: [Date]
• Market Authorization: Approved for [list of indications].
• Pricing and Reimbursement: Negotiations with major payers; coverage depends on therapeutic value. Reimbursement rates influence net price per unit.

Price Projections

Short-term Outlook (Next 1 Year)

• Existing pricing: approximately $X per unit.
• Expected competition entry or patent expiration within Y years.
• Potential for price erosion: 10-15% if major generics enter or biosimilar options are approved.

Mid-term Outlook (2-3 Years)

• Market penetration: projected increase to Z% share.
• Pricing decline: anticipated to stabilize around $Y per unit.
• Potential impact of biosimilar or generic options.

Long-term Outlook (4-5 Years)

• Introduction of biosimilars or generics could reduce the price by 30-50%.
• Further negotiation with payers may sustain higher prices if the drug demonstrates superior efficacy or safety.

Sensitivity Factors

• Patent status: Patent expiry could lead to immediate price drops.
• Market access policies: Changes in healthcare reimbursement policies.
• Regulatory developments: New indications or approvals could alter demand.

Revenue Projections

Scenario	Annual Revenue (USD millions)	Assumptions
Conservative	$X	Market share growth of 10%, stable pricing
Moderate	$Y	Market share of 20%, 15% price erosion expected
Optimistic	$Z	Rapid uptake, no major price erosion

---

Key Takeaways

• The drug with NDC 62135-0477 operates within a competitive landscape with established products.
• Market size is driven by targeted indications and patient access.
• Price projections indicate potential erosion of 10-50% over five years, influenced by patent status and market dynamics.
• Revenue expectations depend heavily on market penetration, reimbursement policies, and competitive threats.

---

FAQs

1. What is the current market price for NDC 62135-0477?
   The price range is approximately $X per unit, depending on the payer and location.

2. When is patent expiration expected?
   Patent expiration is projected for [Year], potentially opening the market for generics.

3. What are the main competitors?
   Key competitors include [Product A], [Product B], which hold significant market shares and are priced between $[lower] and $[upper]**.

4. Will biosimilars affect the price?
   Yes, biosimilar approvals can reduce prices by 30-50% over 3-5 years.

5. What factors could influence future market growth?
   Changes in regulatory policies, expanded indications, improved reimbursement, and market penetration strategies.

---

References

[1] IQVIA. (2022). Pharmaceutical Market Data.

[2] FDA. (2022). Approval and Regulatory Status.

[3] MarketResearch.com. (2023). Biopharmaceutical Price Trends.